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Abstract
Background: The weight of evidence suggests that women who freely choose to terminate a
pregnancy are unlikely to experience significant mental health risks, however some studies have
documented psychological distress in the form of posttraumatic stress disorder and depression in
the aftermath of termination. Choice of anaesthetic has been suggested as a determinant of
outcome. This study compared the effects of local anaesthesia and intravenous sedation,
administered for elective surgical termination, on outcomes of pain, cortisol, and psychological
distress.
Methods: 155 women were recruited from a private abortion clinic and state hospital (mean age:
25.4 ± 6.1 years) and assessed on various symptom domains, using both clinician-administered
interviews and self-report measures just prior to termination, immediately post-procedure, and at
1 month and 3 months post-procedure. Morning salivary cortisol assays were collected prior to
anaesthesia and termination.
Results: The group who received local anaesthetic demonstrated higher baseline cortisol levels
(mean = 4.7 vs 0.2), more dissociative symptoms immediately post-termination (mean = 14.7 vs
7.3), and higher levels of pain before (mean = 4.9 vs 3.0) and during the procedure (mean = 8.0 vs
4.4). However, in the longer-term (1 and 3 months), there were no significant differences in pain,
psychological outcomes (PTSD, depression, self-esteem, state anxiety), or disability between the
groups. More than 65% of the variance in PTSD symptoms at 3 months could be explained by
baseline PTSD symptom severity and disability, and post-termination dissociative symptoms. Of
interest was the finding that pre-procedural cortisol levels were positively correlated with PTSD
symptoms at both 1 and 3 months.
Conclusion: High rates of PTSD characterise women who have undergone surgical abortions
(almost one fifth of the sample meet criteria for PTSD), with women who receive local anaesthetic
experiencing more severe acute reactions. The choice of anesthetic, however, does not appear to
impact on longer-term psychiatric outcomes or functional status.
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Despite the high rate of elective abortions, controversy
still exists about the psychological risks associated with
this procedure. On the one hand, while the weight of evi-
dence suggests that when women freely choose to termi-
nate a pregnancy they are unlikely to experience
significant mental health risks [1-3], some studies have
documented psychiatric disorders such as posttraumatic
stress disorder (PTSD) in the aftermath of termination [4-
6]. Several factors have been associated with post-termina-
tion responses, including type of abortion procedure and
age. With regards to age some studies have found that
younger age may be associated with a higher risk of nega-
tive responses post-abortion [7,8], while others that have
compared psychological responses in adolescents under
18 years of age with those over 18 have shown no differ-
ences [2].
Notably, no significant differences in anxiety or depres-
sive symptoms have been documented in women under-
going medical or surgical termination [9,10]. However, in
women who undergo surgical termination, awareness
during anaesthesia especially if it is associated with pain,
[11] may be so traumatic so as to place some women at
risk of developing PTSD [12]. Seeing the foetus may be
traumatic [7], while awareness or consciousness during
experiences of blood, pain and death (of the foetus) have
also been associated with PTSD-type symptoms [10],
namely re-experiencing (cycle of intrusion and denial),
avoidance (numbing) and perception of the termination
as traumatic [6].
Several studies, mostly retrospective, have described the
development of PTSD in patients who experience aware-
ness under anaesthesia for various surgical procedures
[13-15]. However, findings have not been altogether con-
sistent. For instance, Slade et al. [10] documented more
postabortion distress (including nightmares, flashbacks,
and unwanted thoughts related to the procedure) in
women who received general anaesthesia (GA) (with pre-
sumably no or little intraoperative awareness) compared
with women who received local anaesthesia (LA).
The trend to perform surgical abortions under LA rather
than GA is growing, with many clinics now providing sup-
plementary medication in the form of conscious/intrave-
nous sedation (IS) (i.e., opioid analgesia) in an effort to
improve pain control. However, the benefit of IS in
women undergoing abortions is unclear. It has been
noted that women who receive IS report less subjective
distress and pain than those who receive LA [16,17]. On
the other hand, it has been suggested that IS improves
patient satisfaction but not pain [18,19]. For example,
Rawling & Wiebe [20] and Wiebe [21] found no or ques-
tionably significant relief in women who received IS.
In view of the lack of prospective studies on introperative
and postoperative effects of pain and awareness on long-
term psychological, social and physical well-being, this
study was conducted to examine the effects of elective sur-
gical pregnancy termination on mental and physical
health status when IS versus traditional LA techniques are
used.
We aimed to determine if either LA or IS predicted post-
traumatic stress disorder, depression, anxiety or physical
ill health in women at 1-month and 3-month follow-up,
and to examine other predictors (e.g. pain, self-esteem,
age of woman, gestational age, cortisol), if any, of post-
abortion PTSD at 3 months. We hypothesized that
women who received IS would have significantly less
pain, PTSD, depression and anxiety symptoms compared
with women who received no sedation. Based on previous
findings, we also expected baseline cortisol levels to be
inversely correlated with PTSD at 3 months. PTSD is
known to be characterized endocrinologically by an alter-
ation of hypothalamic-pituitary-adrenocortical (HPA)
axis function with lowered cortisol secretion [22]. There is
evidence, too, for a longitudinal inverse correlation
between PTSD symptoms and morning salivary cortisol
levels [23], although this has not been well characterized.
Methods
Subjects
155 consecutive referrals (80 from a private abortion
clinic in Cape Town and 75 from a state-funded secondary
level general hospital with an obstetrics/gynaecology
unit) were recruited. Referrals were women undergoing
surgical termination of pregnancy under local anaesthesia
or sedation. Both sites offered local anaesthesia and seda-
tion and the choice of anaesthetic was determined by
patient preference. To be eligible, women had to be 16
years of age and older, be at 6–20 weeks of gestation, have
an unintended pregnancy that was not the result of rape,
and be fluent in English. Women were invited to partici-
pate at the time they received counselling for their termi-
nation.
The mean age of participants was 25.4 years (range: 16 –
41 years; SD: 6.1 years), with 34% of women in the 16 to
21 year age group. Age differences were evident between
the anaesthetic groups, with women in the IS group signif-
icantly older than women in the LA group (27.5 ± 6.6
years vs. 24.2 ± 5.4 years, t = 3.2, p = 0.002).
There were no significant group differences with respect to
ethnicity, marital status, number of children, previous
miscarriages, previous abortions, or previous assault his-
tory. Most women were of mixed ethnicity [Coloured]
(48.3%) and were living with a partner (55.6%). 51.7% of
participants had one or more living children. 59.0 % hadPage 2 of 9
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ously miscarried. Approximately 42% of women had
experienced some type of assault in their lives, with the
most common forms of assault being mugging (10.6%),
rape (9.3%) and domestic violence (9.3%).
Procedure
This study was conducted with the approval of the Com-
mittee for Human Subjects at the University of Stellen-
bosch, and was in compliance with the Helsinki
Declaration. Written, informed consent was obtained
from all subjects prior to enrolment. Participants were
assured that their responses would be confidential and
anonymous, and that refusal to participate would in no
way jeopardise their management. Eligible women were
interviewed at 4 time points. A pre-termination assess-
ment (T1) was conducted approximately 1–3 hours prior
to the procedure and prior to administration of anaes-
thetic. The termination procedure followed (this varied in
duration from 5 to 35 minutes). Follow-up question-
naires were then completed in the recovery room just
prior to discharge (T2), then at 1 month (T3) and at 3
months (T4) post-procedure. All assessments were done
in person, except for the 3-month assessment (T4) which
was telephonic. A Demographic Questionnaire was
devised for the study and included information on age,
ethnicity, religion, marital status, education, socio-eco-
nomic level, prior medical/surgical/psychiatric history,
prior live births, prior abortions. The research psycholo-
gist who conducted the assessments was blind to the
anaesthetic status of subjects.
Anaesthesia
The local anaesthetic used at both centres was Petercaine
1% injection (i.e. 10 mg per ml of lignocaine hydrochlo-
ride monohydrate). In addition, women at the state hos-
pital received pre-medication comprising indomethacin
(100 mg suppository) and diazepam (10 mg orally). The
sedation was done using one of two combinations: Pro-
pofol 1% (20 ml) + Alfentanyl 1 mg (2 ml) + Ketamine 20
mg (2 ml) or Propofol 1% (20 ml) + Ramifentanyl,
administered intravenously. The induction dose was 0.85
mg per kg (Propofol) and increased as necessary to
achieve the desired effect. Duration of administration var-
ied according to patient needs and duration of procedure.
All patients (local anaesthetic and sedation) received Mis-
oprostol (400 mg/800 mg/1200 mg) and those undergo-
ing sedation also received Midazolam 7.5 mg ± 2 hours
orally pre-op. Use of these methods was dependent on the
locale of the procedure, approaches of the providers,
wishes of, and affordability to the participant.
Instruments
The following were administered at the pre-termination
assessment (T1):
1. Visual Analogue Scale [VAS] for pain
The VAS consists of a 10 cm line with the endpoints 0 ('no
pain') and 10 ('worst pain').
Participants are asked to indicate their current pain inten-
sity on the scale using a cross (X). The VAS is a widely used
measure of pain intensity and has also been shown to
have adequate sensitivity to change in pain associated
with treatment across many populations and settings [24].
2. Clinician-Administered PTSD Scale [CAPS-1]
The CAPS [25] has become the 'gold' standard for out-
come studies in PTSD. It provides current and lifetime
PTSD diagnostic information in addition to frequency (0
= never; 4 = daily or almost every day) and severity (0 =
none; 4 = extreme) scores of individual PTSD symptoms.
Participants are asked to respond to the questions with
reference to the previous week and with a particular
trauma in mind. participants are asked to respond to the
questions with reference to the last week and a particular
trauma in mind at T1, and with reference to the termina-
tion as the index trauma at T3 and T4.
The recommended score of ≥ 50 was used to identify
women with PTSD.
3. Davidson Trauma Scale [DTS]-self report
The DTS [26] is self-rated measure of PTSD comprising 17
items that correspond to each of the DSM-IV symptoms of
PTSD. The respondent rates frequency (0 = never; 4 = daily
or almost every day) and severity (0 = none; 4 = extreme)
for each item on a 5-point scale. A cut-off score of 40 on
the DTS is considered to be indicative of PTSD. As with the
CAPS, participants are asked to respond to the questions
with reference to the last week and a particular trauma in
mind at T1, and with reference to the termination at T3
and T4.
4. Spielberger State-Trait Anxiety Inventory [STAI] state scale
The STAI [27] is a self-rated scale that measures current
anxiety symptoms on a scale of 1 to 4 (1 = almost never;
4 = almost always). A score of ≥ 40 is considered 'high anx-
iety'. The State version of the STAI was used.
5. Beck Depression Inventory
The Beck Depression Inventory (BDI) [28] is a self-rated
measure of depressive symptoms. Respondents choose
from 4 possible answers ranging in intensity from 0 to 3.
As a screening test for depression, recommended cut-off
points are: 0–9 non-depressed, 10–15 mild depression;
16–23 moderate depression; and ≥ 24 severe depression.
6. Rosenberg Self-Esteem Inventory
The Rosenberg Self-Esteem Inventory (RSI) is a well-vali-
dated and widely used measure of self-esteem [29].Page 3 of 9
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(strongly agree) to 4 (strongly disagree). A higher score is
indicative of a better sense of self-worth. The range of pos-
sible scores is 10 – 40, with mean scores below 20 indicat-
ing average responses on the negative side of self-esteem,
and mean scores above 30 indicating average responses
on the positive side of self-esteem [30].
7. Schneier Disability Scale (SDS)
The SDS assesses current and lifetime impairment in 8
domains of functioning and each item is rated separately
for current and most severe lifetime disability on a 5-
point, descriptively anchored scale ranging from 0 (no
impairment) to 4 (severe impairment). The item scores
may be totaled to obtain 2 summary scores, one rating
overall current disability and the other most severe life-
time disability. Alternatively item scores may be consid-
ered individually to provide descriptive information on
the pattern of impairment across domains.
Immediately post-procedure (T2), the following measures
were administered: (i) Visual Analogue Scale (VAS) for Pain
and (ii) Dissociative Experiences Scale-Taxon [DES-T]. The
DES-T, derived from the 28-item Dissociative Experiences
Scale [DES] [31], is an 8-item subscale designed to dis-
criminate pathological from non-pathological forms of
dissociation [32,33]. The scale focuses on pathological
changes in consciousness, such as dissociative amnesia,
depersonalization and derealization. Subjects are asked to
allocate a percentage of time that they experience each
type of dissociative phenomenon (0% – 100%).
All assessments done pre-termination (except for the
demographic and pain assessments) were repeated at the
1-month (T3) & 3-month (T4) follow-up visits.
Data from 151 participants were included in the final
analysis (78 from the private clinic and 73 from the state
hospital). Four patients were excluded owing to missing
data at T1 (pre-termination). Of the 151 participants, 76
% (N = 115) completed assessments immediately post-
procedure, 44 % (N = 67) returned for the 1-month
assessment and 37 % (N = 56) for the 3-month assess-
ment.
Thirty-seven percent of the sample received intravenous
sedation (IS) while 63% received local anaesthetic (LA).
Salivary cortisol
Morning (09 h 00) saliva specimens were collected at pre-
termination (T1). Samples (approximately 5 ml volume)
were collected and stored at -20 degrees celsius, until
assay. Samples were analysed using a commercial radio-
immunoassay.
Ethical issues
Study clinicians did not participate in counselling, ethical
decision-making, or termination procedures and adhered
to stringent anonymity and confidentiality requirements.
In part, owing to anonymity and confidentiality issues
involved in following a termination sample over time,
some of the original sample was lost to attrition.
Statistical analyses
The two groups (LA] vs. IS) were compared on primary
outcome measures (VAS for pain, CAPS for PTSD) in addi-
tion to other demographic and clinical variables, using
chi-square tests (for categorical variables) and student's t-
tests (for numerical variables). Possible associations
between the groups were also analysed, controlling for
other variables. Women were also stratified by age (16–21
and >22 years), and chi-square and student's t-tests were
used to compare responses between the groups. For out-
comes measured across time (e.g., PTSD, depression, self-
esteem, physical health scores), and in comparing base-
line differences of those who dropped out of the study
with those who completed it as well as gestational age of
women with and without PTSD at 3 months, mean differ-
ences between the groups were analysed using student's t-
tests. Correlations were examined among the different
outcomes (e.g. PTSD, depression, self-esteem) using Pear-
son correlation coefficients. The DTS, BDI, and Spiel-
berger scales were categorized into high and low scores
(determined by each scale's recommended cut-off) to
determine thefrequency of cases above the cut-off for clin-
ical significance. In order to determine whether or not
there were any statistically significant differences between
groups over time, we performed GLM Repeated Measures
ANOVAs. The influence of demographic/clinical charac-
teristics on PTSD outcome was examined by simultane-
ously entering variables that emerged as statistically
significant from bivariate analyses into a multiple linear
regression equation to predict PTSD scores at 3-months.
The significant variables were then entered into a stepwise
regression which produced 3 models. The semi-partial
correlation coefficients and betas were computed in order
to evaluate the unique contribution of each predictor var-
iable. For all analyses, statistical significance was set at p
<.05 and all tests 2-tailed.
Results
Differences between LA and IS groups
(i) Pain
Participants who received IS reported less pain, (i.e., sig-
nificantly lower pain scores) than those who received LA
both at baseline (IS: 3.0 ± 2.3; LA: 4.9 ± 3.1; p = 0.000) and
during surgery (IS: 4.4 ± 3.0; LA: 8.0 ± 1.0; p = < 0.005).Page 4 of 9
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No significant differences in PTSD symptom status (CAPS
and DTS total scores) were observed between the groups
at either the 1 month or 3 month assessments. At baseline,
11.3% of the sample met criteria for a diagnosis of PTSD
on the CAPS (IS: 7.3%; LA: 14.1%), 17.5% met criteria at
1 month (IS: 9.4%; LA: 28.0%), and 18.2% at 3 months
(IS: 10.0%; LA: 28.0%). No significant association
between group status (IS/LA) and the three month CAPS
scores was found.
(iii) Other psychiatric outcomes
Women who received IS experienced significantly less dis-
sociation immediately following the procedure than
women who received LA (IS: 7.3 ± 11.3; LA: 14.7 ± 17.6; p
= 0.01). With respect to longer-term outcome, there were
no significant differences in depression, self-esteem, state
anxiety, and disability scores between IS and LA groups at
1 and 3 months.
With respect to depressive symptoms, at pre-termination
21.9% of the sample had scores suggestive of clinical
depression (IS: 21.8%; LA: 23.1%), while at both 1 and 3
months, 20% of women (IS: 13.8%; LA: 25.7%) had
scores suggestive of clinical depression. 63.9% scored
'high' on state anxiety (STAI) at pre-termination (IS:
66.0%; LA: 62.6%), while at both 1 and 3 months, 56.3%
of women (IS: 51.7%; LA: 60.0%) had 'high' STAI scores.
Secondary analyses were conducted to compare women
with and without a PTSD diagnosis on pain and psychiat-
ric symptoms at 1 and 3 months follow-up. Women with
a PTSD diagnosis on the CAPS endorsed significantly
more pain after the procedure at both 1 month (With
PTSD: 7.0 ± 3.3; Without PTSD: 3.9 ± 2.5; p = 0.049), and
3 months (With PTSD: 8.0 ± 2.4; Without PTSD: 3.7 ± 2.4;
p = 0.012). They also had higher CAPS, DTS, anxiety, and
disability scores at 1 month. Notably, those who met
PTSD criteria at 3 months after termination had signifi-
cantly lower depression (With PTSD: 6.8 ± 6.7; Without
PTSD: 27.8 ± 8.2; p = 0.003) and self-esteem (With PTSD:
23.0 ± 1.9; Without PTSD: 31.9 ± 6.1; p = 0.000) scores at
one month than those who did not meet criteria. GLM
Repeated Measures ANOVAs for baseline, 1 and 3 month
CAPS scores, baseline, 1 and 3 month DTS scores, and
baseline, 1 and 3 month BDI scores comparing anaes-
thetic status were performed, while controlling for age,
baseline cortisol, and prior trauma exposure. Results indi-
cated that there was no significant differences between
groups (IS/LA) over time. However there were significant
differences between pre-termination and 1 month DTS
scores (F = 4.52, df = 4,18, p = 0.03) and 1 and 3 month
BDI scores, F = 16.40, df = 2,18, p = 0.00). There were no
significant baseline differences between participants who
dropped out of the study prior to completion and those
who completed it. However, women with PTSD 3 months
after termination were further along in their pregnancy
than those without PTSD (gestational age: With PTSD:
13.2 ± 3.3; Without PTSD: 9.7 ± 4.2; p = 0.023).
(iv) Age
At baseline, younger women (16 – 21 years) endorsed
more depressive symptoms (Younger: 16.2 ± 9.1; Older:
12.7 ± 9.0; p = 0.027) and had lower self-esteem scores
than older women (> 21 years) (Younger: 27.2 ± 6.0;
Older: 30.3 ± 5.6; p = 0.003). They also, reported signifi-
cantly more pain post-termination (Younger: 5.3 ± 3.1;
Older: 3.7 ± 2.8; p = 0.011) and had higher anxiety scores
at 1 month (Younger: 48.2 ± 8.9; Older: 41.9 ± 11.9; p =
0.026) and 3 months (Younger: 48.7 ± 9.0; Older: 41.9 ±
11.9; p = 0.021).
(v) Salivary cortisol
Women in the IS group had significantly lower baseline
cortisol levels than those in the LA group (IS: 0.2 ± 0.2; LA:
4.7 ± 17.6; p = < 0.001). Cortisol levels were positively cor-
related with baseline pain (r = 0.5; p = 0.000) and state
anxiety (r = 0.3; p = 0.006) and negatively correlated with
baseline self-esteem (r = -0.4; p = 0.009). At 1 and 3
months, baseline cortisol correlated positively with total
CAPS scores (i.e. higher baseline cortisol levels were asso-
ciated with more PTSD symptomatology) (r = 0.3; p =
0.043). Additionally, women with "high" anxiety scores at
pre-termination and 1 month after the procedure had
higher baseline cortisol levels than those with "low" anx-
iety scores (High anxiety: 0.5 ± 0.6; Low anxiety: 0.3 ± 0.2;
p = 0.024).
In summary, women who received IS reported signifi-
cantly less pain before and during the procedure, and had
less severe dissociation and lower baseline cortisol than
women who received LA.
Predictors of PTSD at 3 months
To determine which variable/s, if any, independently pre-
dicted CAPS PTSD scores at 3 months, variables that
emerged as statistically significant in bivariate analyses,
namely PTSD (CAPS) scores at baseline, disability at base-
line (Schneier) and post-termination dissociation (DES-
T) were entered as predictor variables into a forward step-
wise linear regression analysis. This procedure produced
three models. The first model retained baseline CAPS
scores and accounted for 44.7% (adjusted R2 = 0.43) of
the variance in 3-month CAPS scores. The second model
retained CAPS and disability scores at baseline and
accounted for 57.1% (adjusted R2 = 0.54) of the variance
in PTSD symptoms. The third model retained CAPS and
disability scores at baseline and post-procedural dissocia-
tion. This model accounted for 66.1% (adjusted R2 =
0.62) of the variance in PTSD symptoms. The semi-partialPage 5 of 9
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order to determine the unique contribution of each pre-
dictor variable.
Discussion
Our results do not demonstrate any notable long-term dif-
ferences in outcome between the two groups (sedation/
LA). Thus, PTSD, depression, state anxiety, and disability
were not associated with the type of anaesthesia received.
Although not statistically significant, women who under-
went local anaesthesia were more likely to meet PTSD cri-
teria.
The CAPS was used to establish a diagnosis of PTSD based
on traumatic event exposure prior to termination and, at
subsequent assessments, a diagnosis of PTSD secondary to
the termination procedure. The point prevalence of PTSD
at baseline was 11.3%, which is comparable with US com-
munity norms [10] but lower than the rate obtained in
another local community study [34]. The prevalence of
PTSD after termination was 17.5% and 18.2% at one and
three months respectively. This is higher than the rate
found by Rue et al. [5] in American and Russian women
(14.3% and 0.9% respectively), but lower than that found
in other studies of pregnancy loss, for example, by Engel-
hardt et al. [35]. Of note, PTSD symptom status at 3
months was predicted by baseline (pre-termination)
severity of PTSD symptoms and the level of pain experi-
enced, but was not predicted by the presence of other psy-
chopathology (depression, state anxiety, self-esteem, and
functional disability. Women with PTSD were more likely
to be further along in their pregnancies. This has been
noted in studies by Grimes and Cates [36] and Davies et
al. [37], and has been explained on the basis that women
in an earlier stage of pregnancy have had a shorter rela-
tionship with the foetus, are less likely to have experi-
enced foetal movements and, as such, may be at lower
risk. In addition, high levels of pre-existing PTSD and
functional disability, as well as post-termination dissocia-
tion appear to contribution to PTSD in the longer term in
this population. Thus it would follow that screening
women pre-termination for PTSD and disability and post-
termination for high levels of dissociation is important in
order to help identify women at risk of PTSD and to pro-
vide follow-up care. Both dissociation [38] and pre-exist-
ing PTSD [39,40] have been identified as risk factors for
PTSD in other trauma populations.
Baseline rates of depression (21.9% had scores indicative
of clinical depression) and general anxiety (63.9% had
high STAI scores) were also high, with prevalence rates
similar to those found in other studies. For example, in
their review, Bradshaw and Slade [41] observed that prior
to termination, levels of 'caseness' on measures of anxiety,
depression and overall psychological distress ranged from
15 to 69%. Anxiety scores in the present study are also
comparable with those documented in pre-operative sam-
ples [42]. However, rates of depression, and state anxiety
(as measured on the DTS, BDI and Spielberger, respec-
tively) at post-termination did not differ significantly
from pre-termination rates. Rates of depression were sim-
ilar to population based rates in the US [8] but much
lower than found previously in a local sample (Carey et
al., 2003) [34]. Similar to the findings reported here, sev-
eral other studies have found lower levels of depression
[7,43,8]) and lower state anxiety scores [44] post-abortion
compared with pre-abortion.
The finding of lower baseline pain levels in women who
received IS is consistent with observations by Wells [16]
and Rawlings and Weibe [17,20]. At post-termination, the
LA group reported higher levels of dissociation than the IS
group. It could be argued that higher levels of pain in the
LA group might have contributed to a greater propensity
to dissociate. For example Duckworth et al. [45] observed
that rates of dissociation were generally higher in persons
with pain, even among "non-traumatised" patients.
Higher cortisol levels in the local anaesthesia group were
consistent with the greater experience of pain. Other stud-
ies, for example Zimmer et al. [46], have also shown sig-
nificant correlations between pain and cortisol levels.
Additionally, in this sample higher pre-procedural corti-
sol levels were positively correlated with PTSD symptoms
at 1 month and 3 months. The correlation between corti-
sol and pain and cortisol and anxiety in this study may
further be representative of the association between anxi-
ety and pain as suggested by Belanger, Melzack & Lauzon
[47] and Taenzer [42]. However, whether higher baseline
cortisol is an etiologic marker of PTSD symptom severity
or is merely an epiphenomenon of some other process
remains unclear and warrants further investigation.
Pain intensity has been significantly correlated with sub-
jective distress [16], including stress and anxiety [48] and
it has been suggested that the experience of pain during
termination cannot be separated from the anxiety and
trepidation that are experienced before the procedure
[19]. In fact, the level of pre-abortion anxiety has been
positively associated with pain experienced during abor-
tion [47] and is consistent with the role of anxiety in pain
perception and response [42]. Consistent with findings
from previous investigations [16], pain and PTSD symp-
toms tended to co-occur in the sample.
There are several limitations to this study. First, there was
a high rate of attrition over the course of the study leaving
a small final sample (37% of the original sample). It
might be that participants who were lost to follow-up
were lost because of their higher levels of postabortionPage 6 of 9
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Table 1: Comparison of Clinical Outcomes in Women receiving Intravenous Sedation (IS) versus Local Anaesthetic (LA)
Pre-termination (N = 151) Post-termination (N = 115) 1 – month (N = 67) 3 – month (N = 56)
Mean p Mean p Mean p Mean p
PTSD (CAPS) IS 9.2 ± 22.7 0.355 N/A 16.1 ± 26.2 0.074 17.2 ± 26.8 0.107
LA 12.9 ± 24.1 29.2 ± 27.4 29.2 ± 27.4
PTSD (DTS) IS 42.2 ± 32.5 0.067 N/A 30.3 ± 30.4 0.712 30.3 ± 30.4 0.701
LA 32.4 ± 26.2 33.2 ± 31.1 33.3 ± 31.6
Depression (BDI) IS 14.5 ± 9.8 0.602 N/A 10.2 ± 9.5 0.29 10.2 ± 9.5 0.279
LA 13.6 ± 8.8 13.0 ± 12.1 13.1 ± 12.2
Self-esteem 
(Rosenberg)
IS 29.8 ± 6.2 0.331 N/A 30.9 ± 6.3 0.175 30.9 ± 6.3 0.152
LA 28.8 ± 5.7 28.7 ± 6.7 28.5 ± 6.8
Anxiety (Spielberger) IS 44.4 ± 12.0 0.645 N/A 41.1 ± 10 0.149 41.4 ± 10.7 0.142
LA 43.4 ± 10.6 45.5 ± 11.7 45.6 ± 11.9
Disability (Schneier) IS 4.8 ± 4.6 0.138 N/A 2.8 ± 4.0 0.327 2.8 ± 4.0 0.401
LA 3.6 ± 3.2 3.9 ± 4.3 3.8 ± 4.3
Cortisol IS 0.2 ± 0.2 0.001 N/A N/A N/A
LA 0.5 ± 0.5
Dissociation (DES-T) IS N/A 7.3 ± 11.3 0.01 8.1 ± 13.0 0.142 8.1 ± 13.0 0.213
LA 14.7 ± 17.6 14.4 ± 20.4 13.3 ± 19.7
• CAPS: Clinician-Administered PTSD Scale
• DTS: Davidson Trauma Scale
• BDI: Beck Depression Inventory
• DES-T: Dissociative Experiences Scale-Taxon
Table 2: Variables Demonstrating a Significant Association with PTSD Status at 3 months
Variable PTSD No PTSD
3 month mean and SD
Baseline PTSD (CAPS) score* 52.6 ± 30.7 7.5 ± 17.8
Post-abortion pain score* 8.0 ± 2.4 3.9 ± 2.8
1 month PTSD (CAPS) score** 81.6 ± 14.3 11.5 ± 16.9
1 month PTSD (DTS) score** 93.0 ± 17.7 20.9 ± 19.7
1 month Anxiety (STAI) score** 58.4 ± 3.3 39.5 ± 8.6
1 month Depression (BDI) score** 6.8 ± 6.7 27.8 ± 8.2
1 month Self-esteem (RSI) score** 23.0 ± 1.9 31.9 ± 6.1
1 month Disability (SDS)** 8.8 ± 2.2 2.89 ± 4.3
*: p < 0.05
**: p < 0.01
Table 3: Partial Correlations and Standard Beta- values
Variables Standard Beta Partial Correlation P
Model 1 Baseline PTSD (CAPS) Score 0.668 0.668 0.000
Model 2 Baseline PTSD (CAPS) Score 0.473 0.413 0.003
Baseline Disability score 0.404 0.353 0.011
Model 3 Baseline CAPS Score 0.432 0.357 0.004
Baseline Disability Score 0.389 0.339 0.007
Post-termination Dissociation 0.303 0.299 0.017
BMC Psychiatry 2007, 7:24 http://www.biomedcentral.com/1471-244X/7/24distress (i.e. PTSD and other psychopathology), resulting
in lowered rates of psychiatric disorder, although our
results indicated no baseline differences between those
who dropped out and those who completed the study.
Second, salivary cortisol samples, although collected in
the morning (within a two hour window) were not all col-
lected at the same time, and there was no control for other
variables known to affect cortisol (time of last meal, caf-
feine consumption, smoking status). Fluctuations in cor-
tisol may have confounded these results and thus should
be interpreted very tentatively. Third, this was not a ran-
domised study as the participants were referred to the
study only after selecting the type of anaesthetic they
would receive. Fourth, sedation was not equally available
as a treatment option across both sites and this may have,
to some extent, biased these results. For example, the use
of ketamine may change the way in which patients
remember the procedure. Fifth, the 3-month follow-up
was conducted telephonically, contrary to the other 3
assessments, and responses may be partially accounted for
by the method of assessment. However, responses at the
1-month and 3-month assessments remained very simi-
lar. Sixth, the majority of participants were of mixed eth-
nicity (coloured) and while this is the majority ethnic
group in the province, these results may not be generaliz-
able to other ethnic groups.
Conclusion
High rates of PTSD characterise women who have under-
gone voluntary pregnancy termination. The type of anaes-
thetic for the termination procedure does not seem to
impact on long-term outcomes, however women who
receive IS appear to fare better on pain and post-termina-
tion dissociative phenomena.
Presently the weight of evidence suggests that abortion
does not cause lasting negative consequences [1,49]. Nev-
ertheless, longitudinal assessment of multiple variables
(e.g., pain, type of termination, anaesthetic procedure,
gestational age, cortisol, trauma-related symptoms and
other psychophysiological markers) that may potentially
impact on subsequent PTSD and major depression is
deserving of further study.
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